var data={"title":"Pramoxine and hydrocortisone: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Pramoxine and hydrocortisone: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6824?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=pramoxine-and-hydrocortisone-patient-drug-information\" class=\"drug drug_patient\">see &quot;Pramoxine and hydrocortisone: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212420\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Analpram E [DSC];</li>\n      <li>Analpram HC;</li>\n      <li>Epifoam;</li>\n      <li>Mezparox-HC;</li>\n      <li>Novacort;</li>\n      <li>Paramox-HC;</li>\n      <li>PramCort;</li>\n      <li>Pramosone;</li>\n      <li>Pramosone E;</li>\n      <li>ProCort;</li>\n      <li>ProctoFoam HC</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212421\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Pramox HC;</li>\n      <li>Proctofoam-HC</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212433\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Anesthetic/Corticosteroid</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212424\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Dermatoses:</b> Topical, rectal: Apply to affected areas 3 to 4 times daily.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45131535\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Dermatoses:</b> Infants, Children, and Adolescents: Topical, rectal: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212425\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45131536\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;margin-left:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45131537\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;margin-left:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212408\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product</p>\n    <p style=\"text-indent:0em;\">Aerosol, foam, rectal:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">ProctoFoam HC: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (10 g)</p>\n    <p style=\"text-indent:0em;\">Aerosol, foam, topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Epifoam: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (10 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cream, topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Analpram Advanced Kit: Pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% [kit includes Analpram HC cream, diosmiplex (Vasculera) tablets, AloeClean wipes, and applicators]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Analpram E Kit: Pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (4 g [DSC], 30 g [DSC]) [kit includes Prax wipes]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Analpram HC: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (4 g, 30 g); pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (4 g, 30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mezparox-HC: Pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (28.4 g) [contains propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">PramCort: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (30 g) [contains propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pramosone: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (30 g, 60 g); pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (30 g, 60 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pramosone E: Pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (30 g, 60 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">ProCort: Pramoxine hydrochloride 1.15% and hydrocortisone acetate 1.85% (60 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Generic: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (30 g); pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (30 g, 60 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gel, topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Novacort: Pramoxine hydrochloride 1% and hydrocortisone acetate 2% (29 g) [contains aloe, benzyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Paramox: Pramoxine hydrochloride 1% and hydrocortisone acetate 2% (28.4 g) [contains aloe, benzyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Lotion, topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Analpram-HC: Pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (60 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pramosone: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (60 mL, 120 mL, 240 mL); pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (60 mL, 120 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ointment, topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pramosone: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (30 g); pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (30 g)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212396\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes: Cream</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212411\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical: Apply a thin film to the affected area. The treated area should not be bandaged or otherwise covered or wrapped as to be occlusive; however, occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. Discontinue the use of occlusive dressings if infection develops. The use of tight-fitting diapers or plastic pants should be avoided in pediatric patients being treated in the diaper area.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Foam: Epifoam: Shake vigorously for 5 to 10 seconds before each use. May apply directly to the affected are or alternatively, may dispense a small amount to a pad and apply to affected areas. Do not insert container into vagina or anus. Disassemble container and cap after each use and rinse with warm water.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Lotion: Shake well before use.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rectal: Proctofoam HC: Shake vigorously for 5 to 10 seconds prior to use. Do not remove cap during use. Hold container upright to fill applicator. Gently insert applicator tip into anus. Only use applicator provided by manufacturer; do not insert any part of the aerosol container in the anus. Clean applicator after each use with warm water.  For perianal application, transfer a small amount on to a tissue and gently rub into affected area.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212410\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Dermatoses:</b> Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212440\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Pramosone may be confused with predniSONE </p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212402\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">See individual agents.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212414\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to pramoxine, hydrocortisone, or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212399\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Adrenal suppression: May cause hypercortisolism or suppression of the hypothalamic-pituitary-adrenal (HPA) axis, particularly in younger children or in patients receiving high doses for prolonged periods. HPA axis suppression may lead to adrenal crisis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Contact dermatitis: May occur; discontinue use if irritation occurs and treat appropriately.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Immunosuppression: Prolonged use of corticosteroids may result in fungal or bacterial superinfection; discontinue if dermatological infection persists despite appropriate antimicrobial therapy.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Systemic effects: Topical corticosteroids may be absorbed percutaneously. Absorption of topical corticosteroids may cause manifestations of Cushing's syndrome, hyperglycemia, or glycosuria. Absorption is increased by the use of occlusive dressings, application to denuded skin, prolonged use, or application to large surface areas.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Elderly: Because of the risk of adverse effects associated with systemic absorption, topical corticosteroids should be used cautiously in the elderly in the smallest possible effective dose for the shortest duration.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric: Children may absorb proportionally larger amounts after topical application and may be more prone to systemic effects. HPA axis suppression, intracranial hypertension, and Cushing syndrome have been reported in children receiving topical corticosteroids. Prolonged use may affect growth velocity; growth should be routinely monitored in pediatric patients.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Avoid use of topical preparations with occlusive dressings or on weeping or exudative lesions.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Rectal foam: Do not insert any part of the aerosol container directly into the anus. Discontinue use if there is no evidence of clinical or proctologic improvement within 2 or 3 weeks after initiation of therapy or if the condition worsens.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212430\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to individual components.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212403\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=10068&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin. <i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ceritinib: Corticosteroids may enhance the hyperglycemic effect of Ceritinib. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ritodrine: Corticosteroids may enhance the adverse/toxic effect of Ritodrine. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212405\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212416\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events have been observed with corticosteroids in animal reproduction studies. Rectal use of pramoxine and hydrocortisone for the treatment of hemorrhoids in the third trimester of pregnancy was not shown to affect birth weight (Ebrahimi 2011). Also refer to Hydrocortisone (Topical)  monograph.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13383353\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to Hydrocortisone (Topical)  monograph.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45131538\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;\">May consider the use of urinary free cortisol test and ACTH stimulation test in patients with suspected hypothalamic-pituitary-adrenal (HPA) axis suppression.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13383354\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">See individual agents. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212413\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:0em;display:inline\">See individual agents.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212415\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Analpram HC Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5-1% (4 g): $31.21</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Analpram HC Singles Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5-1% (4 g): $15.41</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Analpram-HC Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-1% (28.4 g): $248.29</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Hydrocortisone Ace-Pramoxine Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-1% (30 g): $145.58</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5-1% (4 g): $18.30</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Pramosone E External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-2.5% (28.4 g): $231.98</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Pramosone External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-1% (28.4 g): $222.40</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-2.5% (28.4 g): $242.24</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (ProCort Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1.85-1.15% (60 g): $330.30</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Foam</b> (Epifoam External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-1% (10 g): $97.09</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Foam</b> (Proctofoam HC Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-1% (10 g): $170.96</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Novacort External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-2% (29 g): $7,142.40</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Analpram-HC Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5-1% (59 mL): $293.66</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Pramosone External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-1% (118 mL): $352.24</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-2.5% (59 mL): $282.16</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Pramosone External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-1% (28.4 g): $211.57</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-2.5% (28.4 g): $220.39</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F212417\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Epifoam (AE, BH, CY, EG, IL, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Pracort (BD);</li>\n      <li>Prasone (TW);</li>\n      <li>Proctofoam (GB);</li>\n      <li>Proctofoam HC (AE, IL, QA)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Analpram E cream (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; January 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Analpram HC cream (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; April 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Analpram HC lotion (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; February 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ebrahimi N, Vohra S, Gedeon C, et al, &quot;The Fetal Safety of Hydrocortisone-Pramoxine (Proctofoam-HC) for the Treatment of Hemorrhoids in Late Pregnancy,&quot; <i>J Obstet Gynaecol Can</i>, 2011, 33(2):153-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/pramoxine-and-hydrocortisone-drug-information/abstract-text/21352635/pubmed\" target=\"_blank\" id=\"21352635\">21352635</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Epifoam (hydrocortisone/pramoxine) [prescribing information]. Somerset, NJ: Meda Pharmaceuticals; July 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Goedert JJ, Vitale F, Lauria C, et al, &ldquo;Risk Factors for Classical Kaposi's Sarcoma,&rdquo; <i>J Natl Cancer Inst</i>, 2002, 94(22):1712-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/pramoxine-and-hydrocortisone-drug-information/abstract-text/12441327/pubmed\" target=\"_blank\" id=\"12441327\">12441327</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Novacort (hydrocortisone/pramoxine) [prescribing information]. Chicago, IL: Novum Pharma; received August 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Pramcort cream (hydrocortisone/pramoxine) [prescribing information]. Rochester, NY: Rochester Pharmaceuticals; June 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Pramsone Ointment (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; February 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Pramosone cream 1%/1% (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; October 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Pramosone cream 2.5%/2.5% (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Pramosone E cream 2.5%/2.5% (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Pramosone Lotion 1%/2.5% (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; April 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Proctofoam (hydrocortisone/pramoxine) [prescribing information]. Somerset, NJ: Meda Pharmaceuticals; September 2013.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 10068 Version 116.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F212420\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F212421\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F212433\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F212424\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F45131535\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F212425\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F45131536\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F45131537\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F212408\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F212396\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F212411\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F212410\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F212440\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F212402\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F212414\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F212399\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F212430\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F212403\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F212405\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F212416\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F13383353\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F45131538\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F13383354\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F212413\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F212415\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F212417\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/10068|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=pramoxine-and-hydrocortisone-patient-drug-information\" class=\"drug drug_patient\">Pramoxine and hydrocortisone: Patient drug information</a></li></ul></div></div>","javascript":null}